Recently, MedPHA Biotechnology Co., Ltd. was officially recognized as a potential listed enterprise in the Hengqin Guangdong-Macao Deep Cooperation Zone (hereinafter referred to as the Cooperation Zone) and received a plaque!

This event was hosted by the Cooperation Zone Executive Committee and undertaken by the Cooperation Zone Financial Development Bureau. It aims to establish a regular communication and exchange mechanism between the Cooperation Zone and the Shenzhen Stock Exchange, enhance the ability of the Cooperation Zone to cultivate enterprises for listing, and achieve orderly expansion of the Cooperation Zone's potential listed enterprises to form a gradient cultivation pattern.

MedPHA has always been actively preparing for listing with a grand development vision. At present, it has formed a professional listing preparation team and strictly improved the corporate governance structure in accordance with the standards of listed companies. MedPHA plans to further expand financing channels, increase R&D investment, and continuously explore more possible applications of PHA materials to promote the development and transformation of bio-based materials and brain health industries. At the same time, it actively fulfills its social responsibilities and contributes to the construction of a green China, a healthy China, and even the promotion of global sustainable development.

The inclusion of MedPHA in the cooperation zone's reserve cultivation enterprise is not only a high recognition of the company's past achievements, but also a strong support for its future development. MedPHA will take this opportunity to enhance its innovation capabilities, accelerate the pace of industrialization, inject new vitality into the high-quality development of the cooperation zone, and steadily move towards its established development vision and listing goals.